| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |